A new agent, liposomal cisplatin, in the treatment of relapsed or metastatic childhood solid tumors: Toxicity and clinical effectiveness.
Nurdan Taçyıldız(Ankara University), Gülşah Tanyıldız(Ankara University), Emel Ünal(Ankara University), Fikret Asarcıklı(Pediatric Oncology Group), Handan Dinçaslan(Pediatric Oncology Group), Gülsan Yavuz
Cited by 0
Related Papers
Combined immunodeficiency and Epstein-Barr virus–induced B cell malignancy in humans with inherited CD70 deficiency
|The Journal of Experimental Medicine|2016|153
Successful treatment of central venous catheter infection due to <i>Candida lipolytica</i> by caspofungin‐lock therapy
|Mycoses|2011|35
Soy Isoflavones Ameliorate the Adverse Effects of Chemotherapy in Children
|Nutrition and Cancer|2010|30
Retinoblastoma in Turkey: Results From a Tertiary Care Center in Ankara
|Journal of Pediatric Ophthalmology & Strabismus|2013|25